Skip to content

Parallel-Sided Extensively Coated Femoral Stems

by Biomet Manufacturing Corp

510(k) K073637

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK073637 Date20 Mar 2008ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
KWA
Device Class
Class III
Regulation
21 CFR Part 888.3330
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Parallel-Sided Extensively Coated Femoral Stems are semi-constrained, uncemented hip prostheses designed for femoral replacement. These devices feature a parallel-sided cylindrical stem with an extensively coated surface to promote osseointegration and long-term stability in the femur, serving as a replacement for damaged or diseased natural hip components.

Implanted during orthopedic surgery, these stems are manufactured from wrought titanium alloy (Ti-6Al-4V) with a porous coating for uncemented fixation. Supplied as a Class III device under FDA 510(k) clearance (K073637), they are intended for use in hip arthroplasty procedures. The devices are non-sterile and must be sterilized prior to use, adhering to regulatory standards for medical implants.

Other devices from Biomet Manufacturing Corp

See all devices from Biomet Manufacturing Corp →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Parallel-Sided Extensively Coated Femoral Stems in hip replacement surgery?

    These stems are designed as semi-constrained, uncemented hip prostheses to replace damaged or diseased natural femoral components. The parallel-sided cylindrical shape and extensively coated surface promote osseointegration—meaning they encourage bone growth into the implant—for long-term stability in the femur during hip arthroplasty procedures.

  • Are these stems intended for single-use or can they be reused after sterilization?

    The stems are supplied as non-sterile and must be sterilized prior to use, but there is no explicit indication in the data that they are intended for reuse. Typically, uncemented hip stems like these are single-use implants, though sterilization protocols would determine reuse feasibility if required by a facility’s policies.

  • What material is the Parallel-Sided Extensively Coated Femoral Stem made from, and how does that affect its performance?

    The stems are manufactured from wrought titanium alloy (Ti-6Al-4V), a material chosen for its strength, biocompatibility, and corrosion resistance. This alloy provides durability while allowing the porous coating to promote uncemented fixation by enabling bone ingrowth for secure integration into the femur.

  • How do I determine the correct size or model for a patient’s procedure?

    The data lists multiple registration numbers (e.g., 3020282716, 1047843) associated with this device, which correspond to different sizes or models. To select the appropriate size, consult the manufacturer’s sizing guides or surgical planning tools, as these stems are custom-fit to the patient’s femoral anatomy during preoperative planning.

  • What regulatory pathway was followed for FDA clearance of these stems, and what does that mean for clinicians?

    The stems were cleared via a Traditional 510(k) pathway (K073637) under FDA’s Orthopedic (OR) Advisory Committee, with a decision of Substantially Equivalent (SESE) to a predicate device. This means the FDA determined they meet the same performance criteria as a previously approved hip prosthesis, ensuring compliance with safety and effectiveness standards for uncemented femoral stems.